Indoco Remedies has received EU GMP certification from the German Health Authority (Berlin) for its Oral Solid Dosage (OSD) manufacturing facility (Plant III) located at Baddi, Himachal Pradesh. The inspection was carried out from April 22, 2026, to April 27, 2026.
This certification confirms that the facility complies with Good Manufacturing Practice (GMP) requirements as referred in the EC Directive.
Commenting on this development, Aditi Panandikar, Managing Director, Indoco Remedies, said, “The EU GMP certification for our formulations manufacturing plant is a testament to our commitment to delivering high quality products to patients across the globe.”
Last news about this category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy